Zhenrong Tang
- Oncology
- Cancer Research
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Biomedical Engineering
- Co-authors
- Shengchun LiuYang PengBeige ZongFanli QuYihua WangRui ChenHaochen YuHua Tang
- Topics
- Breast Cancer Treatment Studies (8 papers)Ferroptosis and cancer prognosis (7 papers)Cancer Risks and Factors (5 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Zhenrong Tang
29 papers receiving 305 citations
Peers
Comparison fields: 5 of 76
- Oncology 139
- Cancer Research 132
- Molecular Biology 93
- Pulmonary and Respiratory Medicine 82
- Biomedical Engineering 35
Countries citing papers authored by Zhenrong Tang
This map shows the geographic impact of Zhenrong Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenrong Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenrong Tang more than expected).
Fields of papers citing papers by Zhenrong Tang
This network shows the impact of papers produced by Zhenrong Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenrong Tang. The network helps show where Zhenrong Tang may publish in the future.
Co-authorship network of co-authors of Zhenrong Tang
This figure shows the co-authorship network connecting the top 25 collaborators of Zhenrong Tang. A scholar is included among the top collaborators of Zhenrong Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenrong Tang. Zhenrong Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 17 | |
| 9 | 9 | |
| 10 | 8 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 24 | |
| 14 | 11 | |
| 15 | 9 | |
| 16 | 8 | |
| 17 | 6 | |
| 18 | 34 | |
| 19 | 18 | |
| 20 | Phase III study of Ribociclib (LEE011) in combination with Fulvestrant for the treatment of postmenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) who have received no or only one line of prior endocrine treatment : MONALEESA-3 | 3 |
About Zhenrong Tang
Zhenrong Tang is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 30 papers that have together received 309 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Ferroptosis and cancer prognosis (7 papers) and Cancer Risks and Factors (5 papers). The work is most often cited by research in Cancer Research (132 citations), Oncology (139 citations) and Pulmonary and Respiratory Medicine (82 citations). Zhenrong Tang has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Shengchun Liu, Yang Peng, Beige Zong, Fanli Qu, Yihua Wang, Rui Chen, Haochen Yu, Hua Tang, Dan Shu and Ying Ye. Their work appears in journals such as Scientific Reports, Clinical Cancer Research and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.